Literature DB >> 4656609

Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes.

E Bueding, C L Liu, S H Rogers.   

Abstract

1. No species differences between Schistosoma haematobium and Schistosoma mansoni were detected when the I50 of metrifonate for the acetylcholinesterases (AChE) and the cholinesterases (ChE) of these two trematodes were determined in isolated enzyme preparations or following exposure of the intact worms to this drug in vitro.2. S. haematobium appeared to be more affected by AChE inhibition because, after administration of metrifonate to hamsters, a hepatic shift of the parasites was observed with a dose of metrifonate (150 mg (0.6 mmol) per kg) which produced no shift of S. mansoni, although AChE inhibition was comparable in both species.3. Administration of a possible metabolite of metrifonate, dichlorvos, to hamsters resulted in a greater inhibition of AChE and ChE activities of S. haematobium than those of S. mansoni. Furthermore, when schistosomes were incubated with dichlorvos, inhibition of AChE activity of female S. haematobium was significantly greater (P<0.005) than that of both sexes of S. mansoni and of male S. haematobium.4. The discrepancy between the lack of a significant chemotherapeutic effect of metrifonate in hamsters infected with S. haematobium and the clinical results obtained with this organophosphorus compound in human schistosomiasis haematobium is discussed, and the need to conduct similar studies in primates is pointed out.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4656609      PMCID: PMC1666567          DOI: 10.1111/j.1476-5381.1972.tb08145.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  [Study of the toxicity to humans of an organophosphorated insecticide].

Authors:  P BEHEYT; A LEBRUN; J CERF; J DIERICKX; V DEGROOTE
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  A new approach to helminthiasis control: the use of an organophosphorous compound.

Authors:  J CERF; A LEBRUN; J DIERICHX
Journal:  Am J Trop Med Hyg       Date:  1962-07       Impact factor: 2.345

3.  Rapid hepatic shift of worms in mice infected with Schistosoma mansoni after a single injection of tartar emetic.

Authors:  G A BUTTLE; M T KHAYYAL
Journal:  Nature       Date:  1962-05-26       Impact factor: 49.962

4.  The actions of antimonials on glycolytic enzymes of Schistosoma mansoni.

Authors:  T E MANSOUR; E BUEDING
Journal:  Br J Pharmacol Chemother       Date:  1954-12

5.  Experimental schistosomiasis. III. Chemotherapy and mode of drug action.

Authors:  O D STANDEN
Journal:  Ann Trop Med Parasitol       Date:  1953-03

6.  Acetylcholinesterase activity of Schistosoma mansoni.

Authors:  E BUEDING
Journal:  Br J Pharmacol Chemother       Date:  1952-12

7.  Treatment of urinary schistosomiasis. Practice and theory.

Authors:  D M Forsyth; C Rashid
Journal:  Lancet       Date:  1967-01-21       Impact factor: 79.321

8.  Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.

Authors:  R Ferone; J J Burchall; G H Hitchings
Journal:  Mol Pharmacol       Date:  1969-01       Impact factor: 4.436

9.  Some physiological, biochemical, and morphologic effects of tris (p-aminophenyl) carbonium salts (TAC) on Schistosoma mansoni.

Authors:  E Bueding; E L Schiller; J G Bourgeois
Journal:  Am J Trop Med Hyg       Date:  1967-07       Impact factor: 2.345

10.  Effects of administration of an organo-phosphorus compound as an antibilharzial agent, with special reference to plasma cholinesterase.

Authors:  S Hanna; K Basmy; O Selim; S M Shoeb; A Y Awny
Journal:  Br Med J       Date:  1966-06-04
View more
  10 in total

Review 1.  Acetylcholinesterase of Schistosoma mansoni--functional correlates. Contributed in honor of Professor Hans Neurath's 90th birthday.

Authors:  R Arnon; I Silman; R Tarrab-Hazdai
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

Review 2.  Schistosomiasis drug therapy and treatment considerations.

Authors:  K C Shekhar
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 3.  The redox biology of schistosome parasites and applications for drug development.

Authors:  Hsin-Hung Huang; Coraline Rigouin; David L Williams
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Suppression of Schistosoma japonicum Acetylcholinesterase Affects Parasite Growth and Development.

Authors:  Hong You; Chang Liu; Xiaofeng Du; Sujeevi Nawaratna; Vanessa Rivera; Marina Harvie; Malcolm Jones; Donald P McManus
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

5.  Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development.

Authors:  Nelly El-Sakkary; Steven Chen; Michelle R Arkin; Conor R Caffrey; Paula Ribeiro
Journal:  Dis Model Mech       Date:  2018-07-30       Impact factor: 5.758

6.  Novel cholinesterase paralogs of Schistosoma mansoni have perceived roles in cholinergic signalling and drug detoxification and are essential for parasite survival.

Authors:  Bemnet A Tedla; Javier Sotillo; Darren Pickering; Ramon M Eichenberger; Stephanie Ryan; Luke Becker; Alex Loukas; Mark S Pearson
Journal:  PLoS Pathog       Date:  2019-12-06       Impact factor: 6.823

Review 7.  Clustered Regularly Interspaced Short Palindromic Repeats/ CRISPR associated protein 9-mediated editing of Schistosoma mansoni genes: Identifying genes for immunologically potent drug and vaccine development.

Authors:  Pragalathan Naidoo; Zilungile Lynette Mkhize-Kwitshana
Journal:  Rev Soc Bras Med Trop       Date:  2022-08-12       Impact factor: 2.141

8.  Functional characterization of a novel family of acetylcholine-gated chloride channels in Schistosoma mansoni.

Authors:  Kevin MacDonald; Samuel Buxton; Michael J Kimber; Tim A Day; Alan P Robertson; Paula Ribeiro
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

9.  Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.

Authors:  Madhu K Sundaraneedi; Bemnet A Tedla; Ramon M Eichenberger; Luke Becker; Darren Pickering; Michael J Smout; Siji Rajan; Phurpa Wangchuk; F Richard Keene; Alex Loukas; J Grant Collins; Mark S Pearson
Journal:  PLoS Negl Trop Dis       Date:  2017-12-14

Review 10.  Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths.

Authors:  Hong You; Chang Liu; Xiaofeng Du; Donald P McManus
Journal:  Molecules       Date:  2017-09-14       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.